Proton Pump Inhibitors (PPIs) & Kidney Disease: A Legitimate Risk?

Proton-pump inhibitors (PPIs) are among the effective medications for the treatment of gastroesophageal reflux disease (GERD). It is estimated that nearly ~15 million people in the United States use PPIs each year – with omeprazole being the 9th most-prescribed drug in 2019. One concern among PPI users – particularly long-term PPI users – is the …

Read more